Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.34M Buy
29,841
+479
+2% +$66.2K 0.15% 88
2026
Q2
$3.77M Buy
29,362
+3,692
+14% +$432K 0.16% 92
2026
Q1
$3.09M Buy
25,670
+917
+4% +$106K 0.16% 93
2025
Q4
$2.61M Buy
24,753
+3,606
+17% +$338K 0.13% 121
2025
Q3
$1.77M Sell
21,147
-885
-4% -$72.9K 0.1% 144
2025
Q2
$1.74M Sell
22,032
-7,856
-26% -$624K 0.12% 126
2025
Q1
$2.68M Buy
29,888
+681
+2% +$63.6K 0.22% 77
2024
Q4
$2.91M Buy
29,207
+690
+2% +$71.1K 0.26% 64
2024
Q3
$3.24M Sell
28,517
-1,723
-6% -$205K 0.29% 62
2024
Q2
$3.74M Buy
30,240
+750
+3% +$96.6K 0.34% 53
2024
Q1
$3.89M Buy
29,490
+1,889
+7% +$233K 0.37% 50
2023
Q4
$3.01M Buy
27,601
+3,944
+17% +$409K 0.31% 57
2023
Q3
$2.44M Buy
+23,657
New +$2.55M 0.3% 52

Other funds holding MRK

Syon Capital's MRK Position: Q3 2026 in Review

Syon Capital increased its Merck (MRK) stake by 1.6% in Q3 2026, buying an estimated $66.2K and bringing the position to 29,841 shares worth $4.34M. The position accounts for 0.15% of the portfolio, ranked #88.

Syon Capital first reported a position in MRK in Q3 2023 and has held it in 13 quarters since. 3,967 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Syon Capital held 29,841 shares of Merck worth $4.34M as of Q3 2026.
  • Syon Capital bought 479 Merck shares in Q3 2026, an estimated $66.2K.
  • Merck made up 0.15% of Syon Capital's portfolio in Q3 2026, its #88 holding.
  • Syon Capital first reported a position in Merck in Q3 2023 and has held it in 13 quarters since.
  • 3,967 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Syon Capital's 13F filing for Q3 2026, filed 16 Nov 2026.